114 related articles for article (PubMed ID: 37333134)
1. Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.
Li Y; Lim C; Dismuke T; Malawsky DS; Oasa S; Bruce ZC; Offenhäuser C; Baumgartner U; D'Souza RCJ; Edwards SL; French JD; Ock LSH; Nair S; Sivakumaran H; Harris L; Tikunov AP; Hwang D; Del Mar Alicea Pauneto C; Maybury M; Hassall T; Wainwright B; Kesari S; Stein G; Piper M; Johns TG; Sokolsky-Papkov M; Terenius L; Vukojević V; Gershon TR; Day BW
Res Sq; 2023 Jun; ():. PubMed ID: 37333134
[TBL] [Abstract][Full Text] [Related]
2. OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.
Xu Z; Murad N; Malawsky D; Tao R; Rivero-Hinojosa S; Holdhof D; Schüller U; Zhang P; Lazarski C; Rood BR; Packer R; Gershon T; Pei Y
Clin Cancer Res; 2022 Oct; 28(19):4278-4291. PubMed ID: 35736214
[TBL] [Abstract][Full Text] [Related]
3. Sox2
Treisman DM; Li Y; Pierce BR; Li C; Chervenak AP; Tomasek GJ; Lozano G; Zheng X; Kool M; Zhu Y
Neurooncol Adv; 2019; 1(1):vdz027. PubMed ID: 31763624
[TBL] [Abstract][Full Text] [Related]
4. Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition.
Vo T; Balderson B; Jones K; Ni G; Crawford J; Millar A; Tolson E; Singleton M; Kojic M; Robertson T; Walters S; Mulay O; Bhuva DD; Davis MJ; Wainwright BJ; Nguyen Q; Genovesi LA
Genome Med; 2023 May; 15(1):29. PubMed ID: 37127652
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.
Zhang L; He X; Liu X; Zhang F; Huang LF; Potter AS; Xu L; Zhou W; Zheng T; Luo Z; Berry KP; Pribnow A; Smith SM; Fuller C; Jones BV; Fouladi M; Drissi R; Yang ZJ; Gustafson WC; Remke M; Pomeroy SL; Girard EJ; Olson JM; Morrissy AS; Vladoiu MC; Zhang J; Tian W; Xin M; Taylor MD; Potter SS; Roussel MF; Weiss WA; Lu QR
Cancer Cell; 2019 Sep; 36(3):302-318.e7. PubMed ID: 31474569
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models.
Cook Sangar ML; Genovesi LA; Nakamoto MW; Davis MJ; Knobluagh SE; Ji P; Millar A; Wainwright BJ; Olson JM
Clin Cancer Res; 2017 Oct; 23(19):5802-5813. PubMed ID: 28637687
[No Abstract] [Full Text] [Related]
8. SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.
Adolphe C; Millar A; Kojic M; Barkauskas DS; Sundström A; Swartling FJ; Hediyeh-Zadeh S; Tan CW; Davis MJ; Genovesi LA; Wainwright BJ
Mol Cancer Res; 2021 Nov; 19(11):1831-1839. PubMed ID: 34330843
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptomic sequencing identifies subcutaneous patient-derived xenograft recapitulated medulloblastoma.
Gao J; Zhao Y; Wang Z; Liu F; Chen X; Mo J; Jiang Y; Liu Y; Tian P; Li Y; Deng K; Qi X; Han D; Liu Z; Yang Z; Chen Y; Tang Y; Li C; Liu H; Li J; Jiang T
Animal Model Exp Med; 2024 Mar; ():. PubMed ID: 38477441
[TBL] [Abstract][Full Text] [Related]
10. Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq-guided combination with sapanisertib.
Lim C; Dismuke T; Malawsky D; Ramsey JD; Hwang D; Godfrey VL; Kabanov AV; Gershon TR; Sokolsky-Papkov M
Sci Adv; 2022 Jan; 8(4):eabl5838. PubMed ID: 35080986
[TBL] [Abstract][Full Text] [Related]
11. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
[TBL] [Abstract][Full Text] [Related]
12. STAT3 is required for Smo-dependent signaling and mediates Smo-targeted treatment resistance and tumorigenesis in Shh medulloblastoma.
Yuan L; Zhang H; Liu J; Malhotra A; Dey A; Yu B; Jella KK; McSwain LF; Schniederjan MJ; MacDonald TJ
Mol Oncol; 2022 Feb; 16(4):1009-1025. PubMed ID: 34482626
[TBL] [Abstract][Full Text] [Related]
13. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
[TBL] [Abstract][Full Text] [Related]
14. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.
Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q
Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257
[TBL] [Abstract][Full Text] [Related]
16. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma.
Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
[TBL] [Abstract][Full Text] [Related]
17. METTL3 regulates m
Zhang ZW; Teng X; Zhao F; Ma C; Zhang J; Xiao LF; Wang Y; Chang M; Tian Y; Li C; Zhang Z; Song S; Tong WM; Liu P; Niu Y
Cell Rep; 2022 Oct; 41(4):111530. PubMed ID: 36288719
[TBL] [Abstract][Full Text] [Related]
18. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.
Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE
Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression.
Wynn DT; Rodriguez-Blanco J; Long J; Yang F; Shen C; Fei D; Tang HY; Hanson D; Robbins DJ
Neurooncol Adv; 2022; 4(1):vdac144. PubMed ID: 36299796
[TBL] [Abstract][Full Text] [Related]
20. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling.
Wijaya J; Vo BT; Liu J; Xu B; Wu G; Wang Y; Peng J; Zhang J; Janke LJ; Orr BA; Yu J; Roussel MF; Schuetz JD
Cancer Res; 2020 Apr; 80(7):1524-1537. PubMed ID: 31948942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
